Rigel Pharmaceuticals (RIGL) Tops Q1 EPS by 44c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $38.72 +1.12%
Financial Fact:
Income (loss) from operations: -22.74M
Today's EPS Names:
CRMT, More
Financial Fact:
Income (loss) from operations: -22.74M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Rigel Pharmaceuticals (NASDAQ: RIGL) reported Q1 EPS of $0.44. Revenue for the quarter came in at $58.8 million.
For earnings history and earnings-related data on Rigel Pharmaceuticals (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Crusoe in talks to raise $3B in funding - Bloomberg
- Morgan Stanley Downgrades Repsol SA (REP:SM) (REPYY) to Equalweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
